New Antidepressant Pharmaceutical Analysis Reported in the New York Times
This article regarding a new analysis on antidepressant pharmaceuticals such as GlaxoSmithKline's Paxil, appeared in yesterday's New York Times. According to the analysis, antidepressants effectiveness is directly correlated with the severity of the depression being treated. Will findings like this slow down doctors from prescribing antidepressants to patients whose "depression" could only be due to something as simple as PMS or one bad day?
We want to hear what you think! In your opinion, are doctors writing unnecessary prescriptions?
